Cardiff Lexington (CDIX) slashes revenue, accelerates collections, warns of going concern

Cardiff Lexington Corporation (PINK: CDIX) - concise internal update and income-statement highlights.

What's happening inside: management is prioritizing cash collection from its healthcare subsidiary (Nova), changed its settlement realization estimate (49% → 44%) which produced a large revenue/accounts receivable reduction, completed debt-for-equity/preferred exchanges (including issuance of 938,908 shares of Series Y), restated the cash-flow presentation to reclassify $1,953,667 of non‑cash interest, and continues to rely on a growing receivables-backed line of credit to fund operations. The company discloses substantial doubt about going concern and ongoing remediation of internal-control weaknesses.

Key points & statistics
- Revenue Q3 2024: $1,355,641 (Q3 2023: $3,405,859).
- Revenue 9M 2024: $5,149,416 (9M 2023: $9,476,764).
- Change in settlement realization estimate: 49% → 44%; $1,650,474 reduction to accounts receivable and revenue; $1,199,155 reduction to net revenue for 9M 2024.
- Gross profit Q3 2024: $355,040 (vs $2,854,436 prior year Q3). Gross margin Q3 fell from 83.81% to 26.19%.
- Net loss Q3 2024: $(1,977,968); Net loss 9M 2024: $(2,392,657) (9M 2023: $2,781,608 net income).
- Interest expense Q3 2024: $(1,386,041); interest expense 9M 2024: $(1,803,657).
- Preferred stock dividends Q3 2024: $(238,009). Net loss to common shareholders Q3 2024: $(2,215,977).
- EPS (basic, continuing ops) Q3 2024: $(0.16). Weighted average shares (basic) Q3 2024: 14,075,296.
- Cash at 9/30/2024: $1,949,600 (beginning of period $866,943). Net cash provided by financing (9M): $3,014,583; net cash used in operating activities (9M, restated): $(2,043,238).
- Accounts receivable, net: $14,798,220 (9/30/2024).
- Line of credit outstanding: $7,468,971 (9/30/2024); max facility increased (amendments to $8M then $11M).
- Convertible debt (net): $105,000 (9/30/2024) vs $3,807,030 (12/31/2023) after conversions/exchanges.
- Total assets: $23,514,762; Total liabilities: $15,017,811; Stockholders' equity: $3,729,120; Accumulated deficit: $(71,792,589).
- Restatement: reclassification of $1,953,667 non-cash interest from financing → operating cash flows; no change to cash balances or net income figures.
- Going concern: Company discloses substantial doubt and need for additional capital.

Positive aspects (income statement & liquidity)
- Cash increased to $1.95M over the period, driven largely by financing activity.
- Accounts receivable balance ($14.8M) indicates material recoverable revenue potential (subject to settlement rates).
- Significant reduction in convertible debt after exchanges and conversions (reduces immediate dilution/convertible overhang).
- Management took proactive steps to accelerate collections (shorter negotiations, accepting lower settlements) to improve near-term cash flow.

Negative aspects (income statement & risks)
- Sharp revenue decline (Q3 down ~60% YoY; 9M down ~46%) and compressed gross margins (83.8% → 26.2% Q3) driven by lower realized settlement rates and operational disruptions (Florida storms).
- Very high interest expense ($(1.39M) Q3) is the single largest drag on profitability - financing costs are overpowering operating income.
- Recurring net losses (Q3 and 9M 2024) and large accumulated deficit ($(71.8M)) - equity base stressed.
- Heavy reliance on receivables-backed financing (line of credit balance $7.47M) and on future equity/debt raises; financing cost and covenants risk remains significant.
- Preferred dividends and accrued cumulative dividends materially reduce cash available to common shareholders.
- Material weaknesses in internal controls and a restatement (cash-flow classification) increase execution and reporting risk.
- Going-concern disclosure: operations depend on raising additional capital; no assurance of successful financing.

Bottom line
Cardiff Lexington (PINK: CDIX) is actively managing liquidity by accelerating receivable collections and restructuring debt into preferred equity, which improved cash and lowered convertible debt. However, revenue and margins have fallen sharply, interest costs remain outsized, and the business remains dependent on external financing and remediation of internal controls. The near-term outlook hinges on collection rates, line-of-credit management, and the company's ability to raise capital on acceptable terms.

If you want, I can convert this into a short executive memo or a one‑page investor bulletin with the same figures.